On December 9^th, members of the 1^st IMPACT Cohort joined the M2D2 team for a night of networking with key leaders in the Massachusetts healthcare innovation ecosystem. During this in-person event, IMPACT startups shared lightning pitches of their innovations and met with partners and sponsors of M2D2.

10 startups have been selected to participate in the first cohort of the IMPACT Accelerator Program.

This week, M2D2 announced the finalists for its IMPACT Accelerator Program, a recently launched 12-week program designed to help early-stage companies advance their innovation. These 10 finalists will work closely with M2D2 and its network of experts, receiving 1-on-1 mentorship, education workshops, and access to lab equipment. After the 12-week program, the startups will be part of a public pitch event, where other life sciences startups and investors can learn more about their innovation. 

Tyrpak will be a featured speaker and panelist as part of the UMass M2D2 “Key Considerations & Best Practices” session on June 15.

BUFFALO, N.Y., June 11, 2021 –Stephen Tyrpak, director of clinical & regulatory affairs at Garwood Medical Devices, LLC, will be a featured speaker and panelist at a June 15 virtual event being coordinated by the Massachusetts Medical Device Center (M2D2) at UMass Lowell and sponsored by Johnson & Johnson Innovation – JLABS.

Tyrpak will share his expertise and insights regarding key considerations and best practices related to regulatory strategy in and out of the U.S., the importance of reimbursement considerations early on, and clinical study design and management for early-stage companies seeking regulatory approval. He is one of five participants in the third and final program in the M2D2 Clinical Trial Series.

While we couldn’t safely gather in Boston at Mintz headquarters, this year’s $200K Challenge proved the pandemic couldn’t slow down the innovative minds of startups around the globe. Entrepreneurs, investors, researchers academics and insiders came together after work Wednesday, April 7th for the 2021 $200K Challenge Awards Celebration.

15 finalists have been selected from more than 170 applicants for the 10th Annual M2D2 $200K Challenge.

LOWELL, Massachusetts – The University of Massachusetts Medical Device Development Center (M2D2) today announced the finalists in its 10th annual $200K Challenge after reviewing the 170+ applications.

2021 marks the 10^th anniversary of the M2D2 $200K Challenge, and as the March 24 Finalist Pitch-Off approaches, the excitement is building. Not just for the innovations we’re expecting to see (each year is more amazing than the one before). But also for three big pieces of news: 

As we count down the days to our first International MedTech Forum, we’d like you to meet another Indian Finalist, Nesa MedTech, who will be pitching their idea on Thursday, October 8.

Nesa Medtech is transforming women’s health by developing novel minimally invasive, safe, effective, and uterus-preserving technology to treat uterine fibroids. We talked with their Founder & CEO, Sreekar Kothamachu to learn about their journey.

With less than a week until the International MedTech Challenge, we’d like to introduce you to another unique Finalist from India. Mimyk is building Robotics and AI technologies in endoscopy to enable clinical access to early diagnosis and treatment of GI cancers. We talked to Co-Founder Shanthanu Chakravarthy about the story behind their innovation.

With our first-ever International MedTech Forum right around the corner, we are thrilled to introduce you CyGenica. They are one of the 6 unique Indian life sciences startups pitching their innovations on Thursday, October 8th.